Kwon, Paul
Vyne Therapeutics (United States)
2 papers on CoChat
Most cited papers
- Verified
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
Ständer, S., Kwon, P., Hirman, J., Perlman, A. J., Weisshaar, E., Metz, M., & Luger, T. A. (2019) · Journal of the American Academy of Dermatology
Dermatology and Skin DiseasesUrticaria and Related Conditions
Cited by 118
- Verified
The NK1 receptor antagonist serlopitant for treatment of chronic pruritus
Ständer, S., Spellman, M. C., Kwon, P., & Yosipovitch, G. (2019) · Expert Opinion on Investigational Drugs
Dermatology and Skin DiseasesUrticaria and Related Conditions
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free